1. Home
  2. DDS vs HALO Comparison

DDS vs HALO Comparison

Compare DDS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dillard's Inc.

DDS

Dillard's Inc.

HOLD

Current Price

$610.01

Market Cap

9.5B

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$69.50

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DDS
HALO
Founded
1938
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
8.8B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
DDS
HALO
Price
$610.01
$69.50
Analyst Decision
Sell
Buy
Analyst Count
3
11
Target Price
$519.67
$78.64
AVG Volume (30 Days)
111.1K
1.5M
Earning Date
05-14-2026
05-05-2026
Dividend Yield
5.55%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.22
Revenue
N/A
$151,862,000.00
Revenue This Year
$0.99
$28.24
Revenue Next Year
$1.09
$12.56
P/E Ratio
$18.08
$57.98
Revenue Growth
N/A
N/A
52 Week Low
$396.99
$51.06
52 Week High
$741.98
$82.22

Technical Indicators

Market Signals
Indicator
DDS
HALO
Relative Strength Index (RSI) 57.71 52.91
Support Level $601.54 $67.94
Resistance Level $635.05 $70.93
Average True Range (ATR) 21.52 2.00
MACD 2.71 0.07
Stochastic Oscillator 73.52 60.42

Price Performance

Historical Comparison
DDS
HALO

About DDS Dillard's Inc.

Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: